Pair Name | Dihydroartemisinin, Sorafenib | ||
Phytochemical Name | Dihydroartemisinin (PubChem CID: 3000518 ) | ||
Anticancer drug Name | Sorafenib (PubChem CID: 216239 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Dihydroartemisinin, Sorafenib | |||
Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
Biological Phenomena | Induction-->Ferroptosis | |||
Gene Regulation | Down-regulation | Expression | GCLC | hsa2729 |
Down-regulation | Expression | GPX4 | hsa2879 | |
Down-regulation | Expression | GSS | hsa2937 | |
Down-regulation | Expression | HMOX1 | hsa3162 | |
Up-regulation | Expression | ROS1 | hsa6098 | |
Down-regulation | Expression | SLC7A11 | hsa23657 | |
Up-regulation | Expression | SMG1 | hsa23049 | |
In Vitro Model | Hep-G2 | Hepatoblastoma | Homo sapiens (Human) | CVCL_0027 |
SW480 | Colon adenocarcinoma | Homo sapiens (Human) | CVCL_0546 | |
In Vivo Model | 5×10⁶ of HepG2 cells were injected into the right flank of 6-week-old athymic female mice (Balb/c nude mice). | |||
Result | DHA and Sora had the same mechanism, and the combined application of them could have a synergistic anti-tumor effect by inducing ferroptosis and inhibiting energy metabolism in HepG2 cells. |
No. | Title | Href |
---|---|---|
1 | Dihydroartemisinin enhances the inhibitory effect of sorafenib on HepG2 cells by inducing ferroptosis and inhibiting energy metabolism. J Pharmacol Sci. 2022 Jan;148(1):73-85. doi: 10.1016/j.jphs.2021.09.008. | Click |